drugset / Trial / NCT05160532

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

NCT05160532

Phase 2 Completed 48 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research is to learn more about treating Symptomatic Knee Osteoarthritis (OA) with an ultrasound-guided hypertonic dextrose injection. Researchers would like to determine best practice for injection frequency and effectiveness of the dextrose injection for symptomatic knee OA.

Timeline

Start
2022-04-10
Primary completion
2025-05-31
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 25 % Other

Indications